News, Press Releases, Events, Awards,
It’s All Here.


Novella Clinical Appoints Vice President, Clinical Operations in Europe

Research Triangle Park, N.C. August 26, 2010. Novella Clinical Inc. announced today that it has appointed Jane Bentley PhD, as Vice President, Clinical Operations. Dr. Bentley is responsible for leading European clinical operations for Novella, as well as promoting the company’s values, vision and growth.
Novella Clinical Inc. Acquires Prologue Research International
Durham, N.C., June 2, 2010.  Novella Clinical announced today the acquisition of Prologue Research International, Inc. (Prologue) an Ohio-based full service Clinical Research Organization (CRO) that focuses exclusively on oncology drug development.
Novella Clinical and OSI Pharmaceuticals Expand Clinical Services Agreement
RESEARCH TRIANGLE PARK, N.C. & MELVILLE, N.Y. -- Novella Clinical Inc. (formerly PharmaLinkFHI) and OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) announced today that the Companies will expand their existing clinical service agreement. Under the terms of the new agreement, effective February 1, 2010, Novella will provide clinical research and related services to OSI for a period of two years as OSI transitions its clinical operations to its new Ardsley, New York campus. Novella will assume use of some of OSI’s facilities in Boulder and employ members of OSI’s Boulder staff.
Novella Clinical Tops Fast 50 List at #2

Research Triangle Park, NC, November 13, 2009 – Novella Clinical was ranked #2 last week at the Fast 50 awards dinner and presentation, sponsored by the Triangle Business Journal and PricewaterhouseCoopers at the Sheraton Imperial.
Novella Clinical Appoints VP to Their Medical Device and Diagnostics Division

Research Triangle Park, N.C. October 6, 2009. Novella Clinical Inc. (formerly PharmaLinkFHI) announced today that it has appointed Kimberly Hunsicker, MSN, CRNP, MBA, as Vice President, Project Management, Medical Device & Diagnostics Division (MD&D). Ms. Hunsicker is responsible for the strategic imperatives of the MD&D division and oversees all MD&D clinical programs, ensuring that timelines and deliverables meet or exceed client expectations.
Three Experienced Companies – Combined For One Goal.
Research Triangle Park, NC – June 22, 2009 – PharmaLinkFHI announced today they have officially changed their name to Novella Clinical. Global growth through the 2008 acquisition of Matrix Clinical in the U.K. made the name change necessary.
PharmaLinkFHI Acquires UK-Based Matrix Contract Research Ltd.
6/9/2008 - PharmaLinkFHI, Inc. (PharmaLink) announced today the acquisition of Matrix Contract Research, LTD, a UK-based Clinical Research Organization (CRO) and flexible clinical staffing company.
PharmaLinkFHI Adds Industry Veteran to Leadership Team
6/2/2008 - PharmaLinkFHI, Inc. (PharmaLink) announced today that it has appointed Frank Santoro, MD as Chief Medical Officer.  Dr. Santoro joins PharmaLink from Protherics, a UK-based biopharmaceutical company specializing in oncology and critical care products where he served as Vice President, Clinical Development and Medical Affairs. 
Bracket

Certified QualityCertified Quality

We don't just say quality... we prove it.


About YouAbout You

Partnering with Novella Clinical is a personal experience.


In Your Own WordsIn Your Own Words

Don't take our word for it.
Bracket